Loading company…
Deerfield-based biopharmaceutical company developing therapies for unmet medical needs, founded in 2016.
Founded in 2016 and headquartered in Deerfield, US, TerSera Therapeutics LLC develops biopharmaceuticals for unmet medical needs and sells its therapies to healthcare providers, hospitals and specialty pharmacies in the US and select European regions. CEO Edward Donovan leads the company. Its most recent deal, on June 1, 2023, moved the company from the Golder Thoma Cressey Rauner XI fund to the GTCR TerSera Continuation Fund, with terms undisclosed. It has executed 2 deals in total.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in